LUOPTIX Trademark

Trademark Overview

On Wednesday, December 18, 2019, a trademark application was filed for LUOPTIX with the United States Patent and Trademark Office. The USPTO has given the LUOPTIX trademark a serial number of 79278414. The federal status of this trademark filing is REGISTERED as of Tuesday, May 11, 2021. This trademark is owned by STADA Arzneimittel AG. The LUOPTIX trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Pharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans

Applicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body [ ; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes ]
luoptix

General Information

Serial Number79278414
Word MarkLUOPTIX
Filing DateWednesday, December 18, 2019
Status700 - REGISTERED
Status DateTuesday, May 11, 2021
Registration Number6344048
Registration DateTuesday, May 11, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 12, 2021

Trademark Statements

Certificate of Correction for RegistrationIn the Statement, class 10 has been corrected per the Restriction dated May 20, 2021, and per the fnote dated June 4, 2021.
Goods and ServicesPharmaceutical preparations and biologic medicines used in the treatment of angiogenesis and ocular diseases and disorders as well as angiogenesis and ocular conditions related to diabetic, oncological, macular and vascular diseases and disorders; dietetic food adapted for medical use; dietary supplements for humans
Translation of Words in MarkThe wording "LUOPTIX" has no meaning in a foreign language.
Goods and ServicesApplicators in the nature of droppers and syringes for administering medications into the human eye, sold empty; medical apparatus for introducing pharmaceutical preparations into the human body [ ; diagnostic apparatus for detecting angiogenesis and ocular diseases and disorders for medical purposes ]

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, February 14, 2020
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSTADA Arzneimittel AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressDE
Party NameSTADA Arzneimittel AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressDE
Party NameSTADA Arzneimittel AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Tuesday, June 7, 2022INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Saturday, February 5, 2022PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Saturday, September 11, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Saturday, August 21, 2021FINAL DISPOSITION NOTICE SENT TO IB
Friday, August 20, 2021FINAL DISPOSITION PROCESSED
Wednesday, August 11, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, July 8, 2021LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Saturday, June 19, 2021LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, June 15, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, June 8, 2021LIMITATION FROM THE IB EXAMINED AND ENTERED
Saturday, June 5, 2021CORRECTION UNDER SECTION 7 ¿ PROCESSED
Friday, June 4, 2021NEW REPRESENTATIVE AT IB RECEIVED
Saturday, May 22, 2021LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 11, 2021REGISTERED-PRINCIPAL REGISTER
Friday, April 2, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, February 10, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, January 12, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 12, 2021PUBLISHED FOR OPPOSITION
Sunday, January 10, 2021NOTIFICATION PROCESSED BY IB
Wednesday, December 23, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 23, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 23, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 3, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 3, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, December 3, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 3, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, December 3, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 2, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 2, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 1, 2020ASSIGNED TO LIE
Tuesday, November 17, 2020ATTORNEY REVIEW COMPLETED
Monday, November 16, 2020LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Friday, September 18, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, July 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 27, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 27, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, July 27, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 27, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 27, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, May 22, 2020LIMITATION OF GOODS RECEIVED FROM IB
Friday, April 10, 2020REFUSAL PROCESSED BY IB
Friday, March 20, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, March 20, 2020REFUSAL PROCESSED BY MPU
Wednesday, March 4, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, March 3, 2020NON-FINAL ACTION WRITTEN
Monday, March 2, 2020ASSIGNED TO EXAMINER
Tuesday, February 18, 2020APPLICATION FILING RECEIPT MAILED
Friday, February 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 13, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

luoptix disorders ocular angiogenesis medical diseases human pharmaceutical apparatus preparations droppers